Neurogastrx is a specialty pharmaceutical company developing transformative therapies to advance the treatment of gastrointestinal (GI) disorders. They focus on developing treatments for GI disorders for which meaningful therapeutic innovation is required to satisfy unmet patient need and disease burden.

Biotechnology

Neurogastrx

Jim O’Mara

Kimberley Cummings

Pam Riarh

Pankaj Jay Pasricha

Deborah Corbelle

Christophe Arbet-Engels

Paul Rogers

James Detore

Cyril De Colle

The Scientific and Medical Team at Neurogastrx spearheads research and development efforts for innovative GI therapies. They are responsible for clinical trial design, regulatory compliance, and ensuring that emerging treatments meet rigorous medical standards, addressing unmet patient needs in the gastrointestinal field.

Scientific and Medical Team

Leadership Team

Scientific and Medical Team

About

Team members

Other teams at Neurogastrx

Leadership Team